R-CHOP protocol: Clinical Trials

2 trials of R-CHOP protocol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Withdrawn 1

Follow R-CHOP protocol: new trials by email Literature Review of R-CHOP protocol trials Research Report on R-CHOP protocol

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib
crizotinib - Systemic Anaplastic Large-Cell Lymphoma
Phase 4WithdrawnJun Zhu2015-07-012016-12-30
LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)
R-CHOP, Highly active antiretroviral therapy, Central nervous system (CNS) prophylaxis - HIV Infections, Diffuse Large B Cell Lymphoma
Phase 4CompletedPETHEMA Foundation502006-10-012009-11-25

Conditions studied

HIV Infections (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Large-Cell, Anaplastic (1)

Sponsors

Jun Zhu (1)  ·  PETHEMA Foundation (1)

Countries

China (1)  ·  Spain (1)

Top investigators

Jun Zhu, MD (1)  ·  Oriol Albert, Dr (1)  ·  Ribera Josep M, Dr (1)

Results publications

PMID 25559471